This webpage summarizes the analyses published in Revez et al. 2020 Nature Communications. It includes the following sections (click on tabs above - documented with code):


Study summary:
Vitamin D deficiency is a candidate risk factor for a range of adverse health outcomes, including psychiatric traits. We conducted a genome-wide association study of 25 hydroxyvitamin D (25OHD) concentration (the main metabolite used to assess vitamin D status) in 417,580 Europeans. We identified 143 independent loci implicating genes involved in lipid and lipoprotein metabolism, dermal tissue properties, and the sulphonation and glucuronidation of 25OHD. Using Mendelian randomization models, we found no robust evidence that 25OHD concentration has causal effects on candidate phenotypes (e.g. schizophrenia), but many phenotypes have (direct or indirect) causal effects on 25OHD concentration, clarifying the epidemiological relationship between 25OHD status and the health outcomes examined in this study.


GWAS summary statistics are available in https://cnsgenomics.com/content/data.